Choose your location
Belgium
English
Belgium
Denmark
Estonia
Finland
France
Iceland
Ireland
Latvia
Lithuania
Luxembourg
Netherlands
Norway
Portugal
Sweden
United Kingdom
Transcript
Global Market Outlook webinar preview with Ritu Vohora
Investing during transition
Video Player is loading.
Our 2025 Global Market Outlook summary video helps you navigate the winding road to normalisationand explores the market implications. The rate‐cutting cycle has begun, but global central banks will continue to bedata dependent.
We anticipate a normalisation of policy at a more gradual pace relative to market pricing. Growthis moderating but remains resilient, and although good progress has been made on inflation, it’s not over until it’sover—and is likely to remain volatile.
Read the full report or watch a replay of the virtual event to learn more.
Transcript
Our 2025 Global Market Outlook helps you navigate the winding road to normalization and explores the market implications. The rate‐cutting cycle has begun, but global central banks will continue to be data dependent. We anticipate a normalization of policy at a more gradual pace relative to market pricing. Growth is moderating but remains resilient, and although good progress has been made on inflation, it’s not over until it’s over—and is likely to remain volatile. Labor markets are easing and are a key area to watch.
Key risks include elevated geopolitical tensions, slowing growth, sticky inflation, and monetary policy missteps. As we navigate this new equilibrium, our portfolio construction themes argue for continued diversification across stocks, fixed income, and real assets.
Bond yields have been on a roller coaster ride as markets preempted policy shifts. Current market pricing impliesupside risk to yields. Cash yields remain attractive, but longer‐duration fixed income is vulnerable. Although creditspreads are tight, all‐in yields look attractive. High yield bonds, bank loans, and emerging market bonds present income opportunities.
Equity markets have been dominated by a handful of stocks. We are likely past the first innings of the AI infrastructure buildout. However, the AI wave isn't over—it’s evolving. And stock selection will be critical. We’re excited about a ‘golden age’ for health care, amid radical innovations such as GLP‐1 drugs and robotic surgery.
As economic growth broadens, we’re encouraged by earnings growth broadening across both sectors and regions. Diversifying into areas with valuation support and robust fundamentals, such as value and small‐cap stocks, seemsprudent. We see select opportunities in underappreciated sectors such as energy, financials, and industrials.
2025 is shaping up to be a dynamic year, and an active approach, focused on fundamentals, will be key.
For investment professionals only. Not for further distribution